Sodium/hydrogen exchanger 3

Description:

Description
  • Accession: P48764
  • Swissprot: SL9A3_HUMAN
  • Organism: Homo sapiens
  • Gene: SLC9A3
  • Target class: Transporter

Drug Relations:

tenapanor
IBSRELA (tenapanor) tablets contain tenapanor hydrochloride as an active ingredient. Tenapanor hydrochloride is a sodium/hydrogen exchanger 3 (NHE3) inhibitor for oral use, an antiporter expressed on the apical surface of the small intestine and colon primarily responsible for the absorption of dietary sodium. In vitro and animal studies indicate its major metabolite, M1, is not active against NHE3. By inhibiting NHE3 on the apical surface of the enterocytes, tenapanor reduces absorption of sodium from the small intestine and colon, resulting in an increase in water secretion into the intestinal lumen, which accelerates intestinal transit time and results in a softer stool consistency. Bioactivity details MOA